TDP Risk With Drug for Chemotherapy-Induced Nausea and Vomiting : Internal Medicine News

Links shared publicly online about this topic.

  • 648
    total visits

TDP Risk With Drug for Chemotherapy-Induced Nausea and Vomiting : Internal Medicine News

internalmedicinenews.com

Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre

View full resource at internalmedicinenews.com

Tags: Heart Disease, Arrhythmia, Nausea, Nausea and Vomiting Medication, Chemotherapy, Anzemet

  • Share

Most Recently Shared on December 17, 2010 at 11:03 pm By:

MedicalNewsNet Bob Finn - Medical News Net

Dolasetron mesylate (Anzemet), used for treating chemo nausea, can cause fatal arrhythmia. @elizmech reports. http://bit.ly/hnRG1r

1 year ago...

Advertisement